Inflammatory Bowel Disease

Top Story

Anti-MAdCAM antibody induces remission in moderate-to-severe UC

May 25, 2017

An investigational anti-MAdCAM antibody was safe, well tolerated and superior to placebo for inducing remission in patients with moderate-to-severe ulcerative colitis in the phase 2 TURANDOT trial.

Preliminary results from this trial were previously shared at ECCO 2015 and DDW 2015, and have now been published in full in The Lancet.

In the Journals

Psychological, dietary interventions show promise for treating abdominal pain in IBD

May 24, 2017
Limited evidence from a systematic review shows psychological interventions focusing on relaxation and stress management, as well as certain dietary interventions, are…
In the Journals

Uceris tablets induce remission in mesalamine-refractory, mild-to-moderate ulcerative colitis

May 24, 2017
A phase 3 randomized controlled trial demonstrated the safety and efficacy of Uceris tablets for induction of clinical and endoscopic remission in patients with…
In the Journals

IBD patients on social media focus on risks rather than benefits of biologics

May 23, 2017
A study of social media posts showed patients with inflammatory bowel disease more often share their concerns about the negative side effects of biologics rather than…
CME Video

JAK Inhibitors

This activity is supported by an educational grant from Receptos.

Janus kinase (JAK) inhibitors have emerged as  novel, orally administered small molecule therapies for the
More »
GI Bookshelf

Chapter 31: Rectal Bleeding Following Craniotomy

From Complicated Cases in GI
More »
Featured
Digestive Disease Week

Digestive Disease Week

Video
Meeting News

VIDEO: Speaker reviews factors that impact response to treatment for Crohn’s disease, ulcerative colitis

March 28, 2017
More »
In the Journals

Anti-MAdCAM antibody induces remission in moderate-to-severe UC

May 25, 2017
An investigational anti-MAdCAM antibody was safe, well tolerated and superior to placebo for inducing remission in patients with moderate-to-severe…

In the Journals

Psychological, dietary interventions show promise for treating abdominal pain in IBD

May 24, 2017
Limited evidence from a systematic review shows psychological interventions focusing on relaxation and stress management, as well as certain dietary…

In the Journals

Uceris tablets induce remission in mesalamine-refractory, mild-to-moderate ulcerative colitis

May 24, 2017
A phase 3 randomized controlled trial demonstrated the safety and efficacy of Uceris tablets for induction of clinical and endoscopic remission in…

In the Journals

IBD patients on social media focus on risks rather than benefits of biologics

May 23, 2017
A study of social media posts showed patients with inflammatory bowel disease more often share their concerns about the negative side effects of…

Meeting News

Crohn’s patients with higher Remicade levels may not benefit from azathioprine

May 22, 2017
CHICAGO — Patients with Crohn’s disease who have high serum concentrations of Remicade may not see additional clinical benefits from…

Meeting News

World IBD Day: Healio recaps top IBD research shared at DDW

May 19, 2017
May 19 is World IBD Day. Created during Digestive Disease Week 2010, World IBD Day is coordinated by the European Federation of Crohn’s and…

Meeting News

Crohn’s patients treated with anti-TNFs have lower risk for death than those treated with corticosteroids

May 18, 2017
CHICAGO — Patients with Crohn’s disease who were treated with anti-TNF agents showed significantly lower risks for death, cardiovascular…

Meeting NewsVideo

VIDEO: Simplified text message-based telemedicine system improves adherence in IBD patients

May 17, 2017
CHICAGO — In this exclusive video, Raymond Cross, MD, associate professor of medicine in the department of gastroenterology and hepatology…

Meeting News

Novel genetic test predicts severity of IBD in children

May 16, 2017
A genetic test developed to characterize intestinal microbiota may help to diagnose inflammatory bowel disease and predict the severity of the…

Meeting NewsVideo

VIDEO: Top take-aways in IBD therapies presented at DDW

May 11, 2017
CHICAGO — In this exclusive video from Digestive Disease Week, William J. Sandborn, MD, professor of medicine, chief of the division of…

More Headlines »
Advertisement
Advertisement